22814 0 22814 0 21409 0 21409 0

Last Updated: 19/12/2024

Semi-synthetic arteminisin (SSA) market dynamics

Objectives

To ensure a sustainable supply of (Artemisinin-based combination therapies) ACTs for malaria treatment, in supporting the uptake of semi synthetic artemisinin.

Principal Institution

PATH, United States

Principal Investigators / Focal Persons

Spike Nowak

Thematic Categories

Health Systems

Date

Nov 2023 — Oct 2026

Total Project Funding

$1.2M

Funding Details
Project Site

United States

SHARE
SHARE